Top 50 Medical Startup Investors in Sweden (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Almi Invest
VC Fund
|
17 | Sweden, United States, Ukraine | Seed, Venture - Series Unknown | Software, Health Care, Information Technology | $230k–$4M |
|
Chalmers Ventures AB
VC Fund
|
13 | Sweden | Pre-Seed, Seed | Software, Biotechnology, Information Technology | $5.8k–$2.3M |
|
Sciety
VC Fund
|
9 | Sweden, Ukraine | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $128k–$6.9M |
|
Hadean Ventures
VC Fund
|
5 | Norway, Sweden, Austria | Series A, Series B | Biotechnology, Health Care, Medical | $4.3M–$79M |
|
Fåhraeus Startup and Growth
VC Fund
|
4 | Sweden, Denmark, Finland | Seed, Venture - Series Unknown, Series A | Medical, Health Care, Biotechnology | $851k–$7.3M |
|
Sophia Bendz
Angel
|
4 | Sweden, Denmark, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Software | $400k–$22M |
|
Sweet Studio
VC Fund
|
4 | Sweden | Pre-Seed, Venture - Series Unknown | iOS, Apps, Audio | $145k–$400k |
|
Partnerinvest Norr
VC Fund
|
3 | Sweden, United States | Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $588k–$6.1M |
|
Inventure
VC Fund
|
3 | Finland, Sweden, United States | Seed, Series A, Series B | Software, Information Technology, Health Care | $549k–$25M |
|
Crowberry Capital
VC Fund
|
3 | Iceland, Denmark, Finland | Seed, Series A, Pre-Seed | Software, Gaming, Health Care | $400k–$17M |
|
Scale Capital
VC Fund
|
3 | Denmark, Norway, Sweden | Seed, Venture - Series Unknown | Software, Information Technology, SaaS | $1M–$6.1M |
|
Per Båtelson
Angel
|
3 | Sweden, United States | Seed, Angel | Health Care, Medical, Medical Device | $1.4M–$4M |
|
Industrifonden
VC Fund
|
3 | Sweden, United States, Denmark | Series A, Seed | Biotechnology, Software, Information Technology | $1.2M–$21M |
|
SEB Venture Capital
VC Fund
|
3 | Sweden, Denmark, United Kingdom | Series A, Series B | Software, Information Technology, FinTech | $1.2M–$23M |
|
Norrsken VC
VC Fund
|
3 | Sweden, United Kingdom, Germany | Seed, Series A | Software, Food and Beverage, Artificial Intelligence | $700k–$56M |
|
Bonit Capital
VC Fund
|
3 | Sweden, United States, Germany | Seed, Series A | Health Care, Medical, Apps | $1.8M–$4.2M |
|
Hampus Jakobsson
Angel
|
3 | Sweden, Denmark, United States | Seed, Angel, Series A | Health Care, Software, Artificial Intelligence | $96k–$30M |
|
Simon Josefsson
Angel
|
2 | Sweden, Germany | Seed, Angel, Pre-Seed | Health Care, Sports, Consumer Goods | $183k–$1M |
|
Flerie Invest
VC Fund
|
2 | Sweden, United States, United Kingdom | Series A, Venture - Series Unknown, Series B | Biotechnology, Health Care, Pharmaceutical | $2.5M–$75M |
|
Creandum
VC Fund
|
2 | Sweden, Germany, United States | Series A, Seed, Series B | Software, Information Technology, Artificial Intelligence | $1.8M–$87M |
|
Anders Nyrén
Angel
|
2 | Sweden | Medical, mHealth, Wireless | ||
|
Novo Holdings
VC Fund
|
2 | United States, Denmark, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $9.9M–$135M |
|
Project A Ventures
VC Fund
|
2 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $1.3M–$75M |
|
3T Invest
VC Fund
|
2 | Sweden | Series A, Seed, Angel | Health Care, Medical, News | $3.2M–$6.5M |
|
Otiva
VC Fund
|
2 | Sweden, France, United Kingdom | Seed, Series A, Series B | Fashion, Lifestyle, Marketplace | $1.6M–$12M |
|
Index Ventures
VC Fund
|
2 | United States, United Kingdom, France | Series A, Series B, Seed | Software, E-Commerce, Internet | $1.5M–$102M |
|
Jovitech Invest
VC Fund
|
2 | Sweden | Seed | Solar, Medical, Recycling | $395k–$1M |
|
Nordic Science Investments
VC Fund
|
2 | Finland, Sweden, United States | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Diagnostics | $373k–$4.6M |
|
LU Ventures
VC Fund
|
2 | Sweden | Venture - Series Unknown, Pre-Seed | Medical, SaaS, Software | $336k–$1.6M |
|
Add Health Media
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Health Care, Medical, Apps | $660k–$1.4M |
|
Uppsala universitet Invest AB
VC Fund
|
2 | Sweden | Seed | Medical, Health Diagnostics, CleanTech | $727k–$1.8M |
|
Heartcore Capital
VC Fund
|
2 | Denmark, United States, Germany | Seed, Series A, Series B | Software, Artificial Intelligence, FinTech | $1.3M–$58M |
|
Metsa Spring
VC Fund
|
2 | Finland, Sweden | Seed, Series A | GreenTech, Sustainability, Chemical | $395k–$8.3M |
|
Life Science Invest
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Medical, Biotechnology, Biopharma | $310k–$4.6M |
|
Karolinska
VC Fund
|
2 | Sweden, Denmark, United States | Seed, Series A | Biotechnology, Health Care, Pharmaceutical | $1.3M–$73M |
|
Sting Capital
VC Fund
|
2 | Sweden | Seed, Pre-Seed | Software, Apps, Medical | $216k–$724k |
|
Josefin Landgård
Angel
|
2 | Sweden, France, United Kingdom | Seed, Pre-Seed, Angel | Health Care, Mobile, Medical | $400k–$5.3M |
|
Noaber
VC Fund
|
2 | The Netherlands, Israel, Germany | Seed, Series A | Health Care, Medical, Fitness | $423k–$20M |
|
Sweet Capital
VC Fund
|
2 | United States, United Kingdom, Sweden | Seed, Series A | Apps, Software, Mobile | $1.9M–$32M |
|
GU Ventures
VC Fund
|
2 | Sweden, United States | Seed, Series A, Venture - Series Unknown | Pharmaceutical, Medical, Health Care | $794k–$73M |
|
Tim Jackson
Angel
|
2 | United Kingdom, United States, Sweden | Seed, Angel, Pre-Seed | Internet, Software, E-Commerce | $170k–$2.5M |
|
GOBIA Enterprises
VC Fund
|
2 | Sweden | Seed, Series A, Venture - Series Unknown | Medical, Health Care, Eyewear | |
|
20 North Street
VC Fund
|
1 | Sweden | Medical, mHealth, Wireless | ||
|
John Bloom
Angel
|
1 | Sweden | Series A | Medical, Software, Health Care | |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | |
|
Zentynel Frontier Investments
VC Fund
|
1 | United States, Sweden | Series A, Seed, Angel | Health Care, Baby, Fitness | |
|
Segulah Medical Acceleration
VC Fund
|
1 | Sweden, Germany, United States | Series A, Series D, Series B | Health Care, Medical Device, Biotechnology | |
|
Innovations Kapital
VC Fund
|
1 | Sweden, Denmark, United States | Series B, Series C | Biotechnology, Health Care, Software | |
|
Jens Mogensen
Angel
|
1 | Sweden | Series A | Medical, Life Science, Biotechnology | |
|
Christian W. Jansson
Angel
|
1 | Sweden | Seed | Medical, Software, Health Care | |
| Access all 281 investors in Sweden Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Almi Invest is Sweden’s most active early-stage venture capital firm, investing in scalable startups across Sustainability, Industry, Tech, and Life Science.We invest from pre-seed to Series A, always co-investing with independent private investors to accelerate innovation and long-term success. Our portfolio spans sustainable solutions,industrial innovation, deep tech, SaaS, and life science, supporting startups that drive economic and environmental progress.With €430 million under management and over 1,000 investments since 2009, we have backed leading companies like MIPS, Tobii, and Neo4j, with notable exits to Google, Apple, Microsoft, and Qlik.Beyond capital, we offer engaged ownership, providing strategic guidance, active board participation, and access to an extensive investor network.Almi Invest is part of the Almi Group and is funded by the European Regional Development Fund, Almi AB, and regional partners.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States, Ukraine
Investor stats
- Total investments: 336
- Round size: Seed $230k–$2.3M; Venture - Series Unknown $579k–$4M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- FirstQFM — FirstQFM is a Stockholm-based quantum technology company building proprietary foundation models for quantum computing.
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Workify — Workify develops a user-friendly SaaS-based digital platform, providing information about assignments and how resources are used.
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Sweden
Investor stats
- Total investments: 249
- Round size: Seed $285k–$2.3M; Pre-Seed $5.8k–$318k
- Lead/follow: 47% lead, 53% follow
Portfolio highlights
- Ambidex AB — helps food retailers create new revenue streams on their refrigeration systems by stabilizing the electricity grid.
- Anferra — Turning hazardous steel waste into clean water and green energy.
- InfiniNode Technologies AB — InfiniNode is a semiconductor IP company that seeks to enable efficient data movement in future compute systems.
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, Ukraine
Investor stats
- Total investments: 46
- Round size: Seed $128k–$2.3M; Series A $439k–$6.5M; Venture - Series Unknown $1.6M–$6.9M
- Lead/follow: 93% lead, 7% follow
Portfolio highlights
- Capitainer — Capitainer enables patients to collect their own volume-defined dried blood spot at home.Capitainer started in 2016. Their technology is a volumetric blood collection device that enables patients to conveniently and safely collect blood samples in the comfort of their own home, our technology is more accurate than today’s solutions. Capitaineroffers impressive cost and environmental savings for healthcare providers managing millions of conventional blood samples annually.
- Everdrone — Advanced drone operations for public safety and emergency response
- Single Technologies — SINGLE TECHNOLOGIES develops a new type of single-molecule-sensitive 3D sequencing system.They provide single-molecule detection, fiber optics, 3D imaging, genomics, sequencing, and 3-D Seq.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B
- Geography: Norway, Sweden, Austria
Investor stats
- Total investments: 32
- Round size: Series A $4.3M–$79M; Series B $4.5M–$75M
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $105M in 2021
Portfolio highlights
- Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
- Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: Sweden, Denmark, Finland
Investor stats
- Total investments: 14
- Round size: Seed $851k–$2.7M; Series A $1.8M–$5.9M; Venture - Series Unknown $1.1M–$7.3M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Aplagon — Aplagon is committed to bringing unique, effective antithrombotic medicines with important safety advantages to patients with unmet needs.
- Fida Biosystems — Quantification and characterisation of complex biology made simple. Study molecular interactions in solution, with only nanoliters of sample. Used by industry leaders.
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
Sophia Bendz - Partner @ Cherry Ventures
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 47
- Round size: Seed $400k–$5.9M; Pre-Seed $800k–$2M; Series A $3.5M–$22M
- Lead/follow: 21% lead, 79% follow
Portfolio highlights
- Starmony — Create a song instantly on your phone by just using your voice. Get professional music production in no time. Release instantly on Spotify and Apple Music.
- Scape — Scape is an AI email client that proactively drafts replies and surfaces what matters. Built for professionals who live in their inbox.
- Wikifarmer — A free online knowledge library where professional or amateur farmers can find best practices on growing their fields more effectively and an online marketplace where farmers can sell their products to buyers directly. Our vision is to create a fair, transparent and profitable environment for all the farming world. Farmers are dedicating theirlives in cultivating their fields, but get the lowest value of all the sales cycle, so we believe they need to receive a more fair share. Buyers have the right to have more options and buy at better prices, so we want to be the ones to solve this inequality in both sides.
We co-found companies, dedicating our in-house team of designers, developers, and marketers to bring ideas to life. With every venture we co-found, our mission is to advance the consumer experience across industries with world-class technology, data-informed design, and lots of heart. Are you an entrepreneur who shares our mission?
Show more...Investment focus
- Industry: iOS, Apps, Audio
- Stage:Pre-Seed, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Pre-Seed $145k–$400k
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Koo! — Koo! is an audio based social networking service that let users record and listen to 1-minute audio clips called Koos.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- Stride Leadership — Stride is the revolutionary leadership product built to help become a confident leader. For too long, we’ve been taught that leadership is an elite act that’s linked to your job title. Now you hold leadership development in your hand, regardless of your age, job title, or seniority.With Stride, you’ll learn what it truly means to lead, and how todo it. We’ll bust common myths and you’ll discover which style of leadership is the best fit for you. Designed by leadership and design experts, Stride will help you learn the mindset required, the basics of leadership, and techniques for dealing with inevitable challenges. Whether you’re new to leadership or you’re a seasoned professional you’ll love learning and forming new habits with Stride.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors. Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Seed, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 69
- Round size: Seed $588k–$2.1M; Venture - Series Unknown $794k–$6.1M
- Lead/follow: 16% lead, 84% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Cold River Games — Crystalfall is an upcoming free online action RPG with customizable skills and an endless endgame, set in a steampunk world.
- Original Creation — Original Creation envisions a sustainable future in which capital is focused on long-term benefits for both people and the environment, and resources are properly managed through circular systems."
- Remos Space Systems — Remos Space Systems simplifies satellite ground operations.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A, Series B
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 176
- Round size: Seed $549k–$5.9M; Series A $1.3M–$17M; Series B $1.3M–$25M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $169M in 2022
Portfolio highlights
- Leetify — We help gamers identify their weaknesses, work on those weaknesses and track their progression.
- UpCloud — World's fastest cloud servers with a 100% uptime SLA! Sign up for a free trial today.
- ONEiO — ONEiO is a cloud-native integration service provider connecting people, processes, and tools – enabling seamless collaboration without traditional integration hassle. Provided as a turn-key solution, as self-service, or something in between. You choose.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more...Investment focus
- Industry: Software, Gaming, Health Care
- Stage:Seed, Series A, Pre-Seed
- Geography: Iceland, Denmark, Finland
Investor stats
- Total investments: 50
- Round size: Seed $1.6M–$4.4M; Pre-Seed $400k–$1.3M; Series A $5.7M–$17M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — fund raised in 2021
Portfolio highlights
- Quanscient — Quanscient develops multiphysics simulation software utilizing quantum computing algorithms to improve simulation technology. Its Computer Aided Engineering (CAE) platform integrates a unique combination of cloud-native multiphysics solvers, advanced cloud computing, and future quantum integration. The platform also offers engineers over ahundredfold increase in simulation throughput to enable fully digital R&D processes, addressing complex technology challenges in industries like fusion energy, 6G/7G, advanced semiconductors, biomedical, automotive, and aerospace.
- Hemi Health — Hemi Health is a Danish digital-first headache and migraine clinic specializing in diagnosis, personalized treatment, and care for headaches using technology like an app for symptom tracking and video consultations.
- Augmented Hearing — Read more about danish audiology scale-up Augmented Hearing, driving the world's most ambitious audiology solutions and innovations.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Scale Capital is an early-stage technology investor, helping Nordic, B2B, and tech founder teams scale and win in the US market.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Venture - Series Unknown
- Geography: Denmark, Norway, Sweden
Investor stats
- Total investments: 28
- Round size: Seed $1M–$4.8M; Venture - Series Unknown $1.4M–$6.1M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Sonair — Make your robot safe, affordable, and efficient with the Sonair 3D ultrasonic sensor.
- Bsure — Manage your user identities in Microsoft Entra, reduce license costs, and increase security with bsure. Be cost-effective. Be secure.
- 6 Robotics OÜ — We exist to strengthen defence, protect nations, and deter conflict in an era defined by unmanned warfare.
Per Båtelson
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Angel
- Geography: Sweden, United States
Investor stats
- Total investments: 6
- Round size: Seed $1.4M–$4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Valar Labs — AI to Make Oncologists Smarter
- Imaginecare — Imaginecare is a self-care support that helps patients with long-term health challenges to a better life. Imaginecare consists of a technical platform supplemented with a range of services and analysis tools that together offer a complete solution for healthcare.
- Care to Translate — We provide medical translations for healthcare professionals and patients. Available in 40 languages, 24/7 on your smart device or browser.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more...Investment focus
- Industry: Biotechnology, Software, Information Technology
- Stage:Series A, Seed
- Geography: Sweden, United States, Denmark
Investor stats
- Total investments: 197
- Round size: Seed $1.2M–$6.2M; Series A $3.3M–$21M
- Lead/follow: 41% lead, 59% follow
Portfolio highlights
- Yangi — Yangi is a provider of environmentally friendly packaging solutions.
- Fyndiq — Fyndiq is an e-commerce platform through which we offer a range of products for bargain hungry shoppers. We provide a sales channel for all types of e-tailers who want to boost their sales in an accessible way. Through Fyndiq individual retailers can effect fully sell of its overstock, while consumers have a one stop shop for bargain productsonline. Fyndiq offers more then 220 000 products to consumers from over 1 100 merchants in Sweden. Fyndiq was founded in Stockholm in August 2009 and launched its platform in august 2010. Since then we have been growing rapidly both in terms of turnover and employees. In 2012 our sales was 56 million SEK, a number we doubled in 2013 to sales of almost 124million SEK. In November 2014 Fyndiq raises $20M to take the platform internationally. The funding is notable in that it was led by one of the more prominent VCs based in the Nordics, Northzone, which was an early investor in Spotify. The other investor in this round, Industrifonden, is a VC backed by the Swedish government that invests in startups from the country to help scale them internationally. Currently we are 75 dedicated and motivated team members who make it all happen.
- Avtal24 — Avtal24 offers in an easily accessible manner agreements for both private individuals and companies. They believe in making the law available to everyone and they want everyone to have access to legal security. With us, you write agreements online or together with a lawyer by phone. Always at a fixed price. With high legal expertise, innovativetechnology and great focus on customer benefit and offer the market's most accessible legal services.Avtal24 was founded in 2004 and is headquartered in Stockholm, Sweden.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more...Investment focus
- Industry: Software, Information Technology, FinTech
- Stage:Series A, Series B
- Geography: Sweden, Denmark, United Kingdom
Investor stats
- Total investments: 72
- Round size: Series A $1.2M–$12M; Series B $2.2M–$23M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $300M in 1995
Portfolio highlights
- Apica — Apica is the agentic-ready telemetry pipeline that cuts observability costs up to 40%. Control your data, eliminate tool sprawl, and scale for AI.
- MobileTag — Mobile Tag, the European leader in mobile barcode solutions, continues to innovate with the launch of its latest application: mobiletag Universal Reader and shopping.Mobile Tag is behind the creation of the flashcode, the standard 2D barcode used by operators in France. This type of Datamatrix barcode is used by the biggest companies indisplay, transportation, distribution, the pharmaceutical industry, and more.Mobile Tag has always tried to develop new technology from the consumer's point of view, and the mobiletag Universal Reader & shopping is no exception.The concept behind this application is to send, receive and share information and best prices to everyone and for everyone through all standardized barcodes.Scanning a barcode with your mobile phone is simply taking a picture of it with your phone, using the mobiletag application. Mobile tag is free!
- CorPower Ocean — CorPower Ocean AB was founded in 2009 to develop high efficiency Wave Energy Converters (WECs).CorPower's Wave Energy Converters deliver five times higher annual energy output per ton of device compared to previously known wave power solutions. The step-change improvement in performance and efficiency allows a Cost-of-Energy that cancompete with offshore wind. The products are currently in pilot with Iberdrola. CorPower has assembled a team with extensive experience in energy generation, design and manufacturing of production equipment, system engineering as well as the market expertise to allow us to continue transforming the technology of tomorrow into renewable energy applications of today.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more...Investment focus
- Industry: Software, Food and Beverage, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Sweden, United Kingdom, Germany
Investor stats
- Total investments: 108
- Round size: Seed $700k–$14M; Series A $4.2M–$56M
- Lead/follow: 31% lead, 69% follow
- Last fund: Likely still investing — raised $340M in 2024
Portfolio highlights
- Biorce — Meet the world's first AI clinical trials assistant! We bring innovative technologies to revolutionize healthcare and drug development faster & more efficiently
- Verse — Define & achieve your financial and emissions reduction goals with Aria, a software platform that helps companies buy and manage clean power.
- Endra — Endra is a purpose-built platform for modern MEP engineering. Generate 3D models and drawings, sync with Revit and enjoy coordinated design workflows.
Bonit Capital is a Swedish family-owned investment company. We invest across sectors and asset classes, including social investments and outcome models.Venture Capital - We invest in ambitious founders within the life science sector. We take an active ownership approach by providing capital, industry expertise and access to an internationalnetwork. Our focus areas are digital health, medical technology and diagnostics.Private Equity - We invest in entrepreneurial teams with deep sector expertise and unique market access, primarily in the lower to mid-market buyout segment, with the aim to produce superior returns and meaningful portfolio diversification.Listed Equity - Our strategy is to obtain a broad market exposure through mainly external mandates, and to seek superior returns in individual shares primarily in life science. Among Bonit's main holdings are the world-leading medtech company Elekta AB, founded by Laurent Leksell.Leksell Social Ventures - LSV is the first impact investor in Sweden with a focus on outcome models and direct investments in the areas of mental health, education and social integration. Striving for systemic change, LSV contributes to social innovation and societal development by giving social entrepreneurs and social ideas the necessary prerequisites to develop and progress – through financing, idea development and networking with private, public and nonprofit actors.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Series A
- Geography: Sweden, United States, Germany
Investor stats
- Total investments: 13
- Round size: Seed $1.8M–$4.2M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Vården.se — Vården.se is Sweden's largest private search service in healthcare and health .
- Bentley — Bentley engages in the development, manufacturing for minimal-invasive treatments of vascular diseases.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.
Show more...Investment focus
- Industry: Health Care, Software, Artificial Intelligence
- Stage:Seed, Angel, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 43
- Round size: Seed $310k–$5.3M; Angel $96k–$1.2M; Series A $2.3M–$30M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
- Mojo — Clinical-grade, AI-powered sperm analysis from the comfort of home. Test your sperm count, motility, morphology and much more with the Mojo kit. Check your fertility from home at low cost - without the need for clinic visits and awkward waiting rooms.
- Volta Greentech — Discover innovative solutions to reduce agricultural emissions with Volta Greentech's science-driven feed additives, promoting sustainable farming and planetary health.
Simon Josefsson
Show more...Investment focus
- Industry: Health Care, Sports, Consumer Goods
- Stage:Seed, Angel, Pre-Seed
- Geography: Sweden, Germany
Investor stats
- Total investments: 12
- Round size: Seed $339k–$1M; Angel $183k–$348k; Pre-Seed $366k–$540k
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Allihoop — Allihoop offers Scandinavian styled co-living homes for people on the move. Beautiful spaces designed to make you feel at home. Available in Stockholm and soon in Paris.
- Stockrepublic — Drive trading volume and retention with StockRepublic. Seamlessly integrate social investing, benchmarking, and insights via API and white-label.
- Care to Translate — We provide medical translations for healthcare professionals and patients. Available in 40 languages, 24/7 on your smart device or browser.
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Venture - Series Unknown, Series B
- Geography: Sweden, United States, United Kingdom
Investor stats
- Total investments: 24
- Round size: Series A $2.5M–$23M; Series B $12M–$75M; Venture - Series Unknown $4.5M–$47M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AnaCardio — AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility and aims to improve clinical outcomes in heart failure.
- Nanologica — Nanologica combines unique know-how in the field of materials technology with a genuine interest in solving real problems in life science. The company works with nanoporous silica which has properties that are attractive in a wide variety of applications. In order to succeed, development work is carried out in close dialog with customers.Nanologica is unique in that it is a world leader in controlling the form, type of porosity and surface area of particles of silica. This competence can be used to produce particles that have the potential to solve problems in diverse application areas. The company’s core competency has been developed and expanded in twoareas of application in particular: drug delivery on the one hand and on the other chromatography, a technology used for the separation and purification of products on the market and in development.The starting point for Nanologica’s work is the material sciences, a field in which the company’s founder has developed and patented completely new materials. The initial research was based at Stockholm University and the Ångström laboratories atUppsala University.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
We support early-stage founders in building global, category-defining companies. From Seed to IPO and beyond.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 285
- Round size: Seed $1.8M–$17M; Series A $5.3M–$35M; Series B $8M–$87M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Passionfroot — A workspace where you can manage your creator business and organise your finances so that you can optimise your creator-work-life balance.
- OLIX — OLIX designs and manufactures optical processors that use light-based circuits to accelerate artificial intelligence workloads. The company develops Optical Tensor Processing Units that execute matrix and tensor operations for training and running inference on large-scale machine learning models. Its hardware aims to increase performance and reducepower consumption relative to conventional electronic accelerators by processing data in the optical domain. Flux Computing focuses on infrastructure for generative AI and advanced neural networks, targeting data centers and organizations that require intensive model computation. The product stack centers on custom optical chips integrated with supporting electronics, control software, and tools that link into existing AI frameworks. Sales and partnerships primarily address customers building large AI clusters, research environments, and emerging applications that benefit from high-throughput, low-energy computation.
- EquiLibre Technologies — The Next Generation of Algorithmic Trading
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Born 1954. Degree from the Stockholm School of Economics and Master of Business Administration from Anderson School of Management, UCLA, USA.Board Member: AB Volvo, Stockholm School of Economics, and Handelshögskoleföreningen at Stockholm School of Economics.Principal work experience and other information: Vice President of the Royal SwedishAcademy of Engineering Sciences since 2014. President and CEO of AB Industrivärden 2001-2015. CFO and Executive Vice President of Skanska AB 1997–2001. Director Capital Markets Nordbanken 1996–1997. CFO and Executive Vice President of Securum AB 1992–1996. President of OM International AB 1987–1992. Previous positions within STC Scandinavian Trading Co AB and AB Wilhelm Becker. Board member in Telefonaktiebolaget LM Ericsson 2006-2013. Honorary Doctorate of Economics at Stockholm School of Economics.
Show more...Investment focus
- Industry: Medical, mHealth, Wireless
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Coala Life — Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and theCoala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Denmark, United Kingdom
Investor stats
- Total investments: 368
- Round size: Series A $9.9M–$133M; Series B $12M–$135M; Series C $30M–$118M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $165M in 2018
Portfolio highlights
- Biosyntia — Biosyntia is a biotech startup within synthetic biology and metabolic engineering. We develop biocatalysts at an unprecedented speed and efficiency by employing our patent pending high-throughput screening technology.By developing tailored processes based on biocatalysis, Biosyntia enables production of complex chemical compounds byfermentation. Biocatalysis may substantially reduce both production costs and environmental impact compared to other processes such as chemical synthesis. We partner with manufacturers of fine chemical compounds (flavors, fragrances, APIs, pigments, additives, intermediates, and more) in order to establish more sustainable manufacturing processes for a greener tomorrow.Biosyntia is located at the Novo Nordisk Foundation (NNF) Center for Biosustainability in Hørsholm, 25 kilometers north of Copenhagen.
- IVERIC bio — IVERIC bio is a science-driven biopharmaceutical company focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inheritedretinal diseases.
- Nkarta Therapeutics — Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.While T-cell therapy, often known as CAR-T, has proven successful in certain cancer indications, its promise has been limited toa few hematologic malignancies and the side effects can be severe. Natural Killer cells are the immune system’s first responders against diseases and pathogens. Unlike T cells, they have an inherent ability to target tumor cells without genetic alteration, and therefore hold significant promise in the development of potent therapies that can be used more readily for diverse tumor types. Nkarta’s differentiated cell therapy approach is designed to boost and enhance the inherent power of Natural Killer cells to target and destroy tumor cells, while also offering a better tolerated safety profile.
Project A is an early-stage venture capital firm, combining financial and operational support for technology companies. In addition to $1bn in assets under management, Project A provides its portfolio companies with a wide range of operational support services. This includes more than 100 experts from key areas such as software engineering,business intelligence, marketing, and recruiting. The portfolio includes companies such as Trade Republic, sennder, KRY, Catawiki, WorldRemit, Spryker, and Voi.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 215
- Round size: Seed $1.3M–$9.7M; Series A $3.3M–$28M; Series B $11M–$75M
- Lead/follow: 35% lead, 65% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Nexcade — Nexcade AI agents run freight quoting, tenders, rates, bookings, and reporting with your team, visible and controlled at every step.
- Project Q — European defence integration. Deployed with Bundeswehr, validated at NATO. Open-core, ITAR-free, no vendor lock-in. Connect sensors to C2 in seconds.
- STARK — EUROPEAN DEFENCE SOVEREIGNTY
3T Invest started an interesting and fulfilling journey back in 2009. From the beginning they focused on the establishment of sustainable Venture Capital, supporting innovation and entrepreneurship. they are always committed to backing outstanding entrepreneurs with the necessary resources.
Show more...Investment focus
- Industry: Health Care, Medical, News
- Stage:Series A, Seed, Angel
- Geography: Sweden
Investor stats
- Total investments: 4
- Round size: Series A $3.2M–$6.5M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Linkura — Linkura offers a Lifestyle Program focusing on actions.
- NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
- Warp News — News that is optimistic and based on facts. The world is better now than ever before, but mainstream media has a negative bias. We balance that.
Equity investment company doing Series A to late growth, private and public. Agile and long-term with no fixed holding period.
Show more...Investment focus
- Industry: Fashion, Lifestyle, Marketplace
- Stage:Seed, Series A, Series B
- Geography: Sweden, France, United Kingdom
Investor stats
- Total investments: 9
- Round size: Seed $1.6M–$3.2M; Series A $3.2M–$12M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- AllPlants — Delicious 100% natural, non-UPF plant-based meals for busy lives. Order today for free delivery, or find us in Tesco, Sainsbury's, Waitrose and Ocado.
- BlaBlaCar — BlaBlaCar is the world’s leading long-distance carpooling community, connecting people looking to travel long distances with drivers going the same way. They travel together and share the costs of the journey. The platform is engineered to create a secure, trust-based community with declared identities and full member profiles. Members can evenspecify how chatty they are from “Bla” to “BlaBlaBla”, hence the name BlaBlaCar. BlaBlaCar is creating a global people-powered network with a trusted community of drivers and passengers.Backed by Accel Partners, Insight Ventures, Index Ventures, Lead Edge Capital, Baring Vostok and ISAI, it operates in 22 countries across Europe, Russia, Turkey, Mexico, Brazil and India. The site and free mobile apps provide a range of features to create a secure, trust-based community and easy connections between drivers and passengers.BlaBlaCar is based in Paris with offices across a dozen of countries.
- Pet Media Group — Woof Woof. Europe's Largest Pet Marketplaces PetMediaGroup is the leading operator of online marketplaces for pets and related goods and services. Through our trusted and local brands, we help thousands of animals every day to find a new loving home as well as assist their human caregivers
Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 1322
- Round size: Seed $1.5M–$15M; Series A $5M–$38M; Series B $11M–$102M
- Lead/follow: 44% lead, 56% follow
- Last fund: May invest from a new fund soon — raised $117M in 2015
Portfolio highlights
- OpenX — OpenX has the largest independent ad exchange network for publishers and demand partners, while maintaining the highest quality marketplace standards. Learn more.
- Shopmonkey — Smart and simple repair shop management software that does it all. Invoices, POS system, CRM, inventory, scheduling, & more. Request a demo today!
- Molecular Partners — Molecular Partners develops DARPin therapeutics for cancer and serious diseases through innovative oncology and radiopharmaceutical programs.
Jovitech Invest help entrepreneur-led companies to grow profitably through active, long-term ownership
Show more...Investment focus
- Industry: Solar, Medical, Recycling
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $395k–$1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- Mat4Green Tech — Mat4Green Tech develops a technology that recycles Indium from industrial waste in an efficient and climate-neutral way.
We partner with founders to transform unseen scientific discoveries into future breakthroughs, jointly moving businesses, people, and the world forward.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Diagnostics
- Stage:Seed, Pre-Seed, Series A
- Geography: Finland, Sweden, United States
Investor stats
- Total investments: 17
- Round size: Seed $373k–$4.6M; Pre-Seed $380k–$837k; Series A $2.9M–$3.9M
- Lead/follow: 88% lead, 12% follow
Portfolio highlights
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- mu-ray.tech — Mu-ray.tech is focused on advancing the field of medical diagnostics and industrial quality control. mu-ray.tech is developing a groundbreaking technology for the rapid, safe and accurate 3D-imaging of the chemical composition of scanned objects, serving critical needs in industrial quality control and medical diagnostics. The technology is basedon Muon Beam Imaging (MBI), an innovative technology leveraging Laser Plasma Accelerator-based artificial muon sources, new generation particle detector systems and AI. In industry, we are working with the partners in the heavy, aerospace, and defence domains.mu-ray.tech operates at the three sites: DESY in Hamburg (hardware), Tehnopol in Tallinn (algorithms and software), and Bradfield Centre in Cambridge (algorithms, business development). Our main collaboration on the MBI technology partners are GScan in Estonia and UK, DESY in Hamburg, the University of Cambridge, and KBFI in Tallinn.
- Perfat Technologies — Perfect fats for better foods.
LU Ventures, part of Lund University Innovation, co-founds spin-off companies with university researchers to commercialize research and drive global impact. It supports academics in building companies while allowing them to stay in academia, funding IP costs, recruiting CEOs/CTOs and board experts, and establishing legal/financialframeworks to attract external capit
Show more...Investment focus
- Industry: Medical, SaaS, Software
- Stage:Venture - Series Unknown, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Venture - Series Unknown $336k–$1.6M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Waveium — Waveium develops a cloud-based SaaS platform that provides instant wireless design simulations and validation for engineers and wireless developers. The platform enables users to test and optimize wireless systems in real time using scalable, automated simulations. It exposes functionality through an API so teams can integrate wireless performancetesting into network planning, product development workflows, and AI training pipelines. Waveium focuses on reducing the time and cost of traditional measurement-based wireless validation while supporting experimentation with new wireless features.
- Cyclicor — Cyclicor is an innovations based company focused on the development and commercialisation of safer and more sustainable polymers. The company was registered in October of 2012 as a spin-off company from the University of Lund in Sweden and began commercial development of its first product Cycli-ClearTM, a bisphenol free polycarbonate, in late 2013.
- Aventera Antibodies — Developing a First-in-Class Therapy for Invasive Group A Streptococcal Infections.
Add Health Media is a company that specializes in creating marketing materials for health companies.
Show more...Investment focus
- Industry: Health Care, Medical, Apps
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 16
- Round size: Seed $660k–$1.4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Eatit — Eatit is a digital therapeutics platform for obesity treatment by dietitians.
- Dropmed — Dropmed is a Stockholm-based startup aiming to digitally transform medical device sales by providing groundbreaking tools for E-Commerce enablement and guided purchasing.
- Migränhjälpen — Migränhjälpen is providing digital health services.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Uppsala universitet Invest AB focuses on investment management, particularly in early-stage ventures. The company collaborates with researchers and students, providing financial support and strategic guidance for innovative projects. It aims for long-term investment horizons, typically ranging from 5 to 15 years. Uppsala universitet Invest AB alsopartners with other investors and co-financiers to support research-driven initiatives.
Show more...Investment focus
- Industry: Medical, Health Diagnostics, CleanTech
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 3
- Round size: Seed $727k–$1.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Caplyzer — Caplyzer develops and patented a new solution for water electrolysis.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
- Readily Diagnostics — Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster and more effective therapy at the point of care.
Heartcore Capital invests in companies re-enchanting the world through technology.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, FinTech
- Stage:Seed, Series A, Series B
- Geography: Denmark, United States, Germany
Investor stats
- Total investments: 206
- Round size: Seed $1.3M–$12M; Series A $3.4M–$27M; Series B $9.6M–$58M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- PhaseTree — Materials design simulation company - PhaseTree ApS
- TrapLight Games — A hard-hitting mobile game studio from Finland. Traplight is a premium mobile games studio with 10+ years of game development expertise at the highest level. Our ambition is to create world class, chart topping, scalable game services.
- Fast Travel Games — Fast Travel Games is a VR exclusive game developer and publisher, founded by industry leading veterans and behind acclaimed titles such as Apex Construct and Wraith: The Oblivion - Afterlife.
We boldly invest in and support promising startups and potential innovations that explore new uses for sustainably-grown Nordic wood.
Show more...Investment focus
- Industry: GreenTech, Sustainability, Chemical
- Stage:Seed, Series A
- Geography: Finland, Sweden
Investor stats
- Total investments: 12
- Round size: Seed $395k–$5.9M; Series A $4.4M–$8.3M
- Lead/follow: 58% lead, 42% follow
Portfolio highlights
- Adsorbi — Adsorbi use cellulose from the Nordic forest to help air purification companies to capture gaseous air pollutants.
- FineCell — FineCell is a sustainable cellulose microfibers provider that enables manufacturers to make new products with reduced carbon footprints and differentiated properties.The company's cellulose microfibers possess physical and chemical properties that differ from competing products and provide differentiated benefits for the users. It has beensupported by Vinnova (Sweden’s innovation agency) and EIT InnoEnergy.The Linköping, Ostergotlands Lan-based company was established in 2015 by Jonatan Henschen, Jonas Engstrand, Monica Ek, and Kloce Dongfang Li.
- Fiberwood — Fiberwood is a new eco-friendly wood fiber insulation that can be used for a variety of purposes. Fiberwood has excellent insulating properties, is entirely bio-based, and thus contains no plastic or other fossil-based materials.
LSI Academy - New education 2026, read more here
Show more...Investment focus
- Industry: Medical, Biotechnology, Biopharma
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 6
- Round size: Seed $682k–$4.6M; Pre-Seed $310k–$500k
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Haga Bioscience — Mission Technology Assays Benefits Team Contact us Focus whereit truly matters. In situ RNA detection at single nucleotide resolution, bridging discovery and translation. Our mission Bridging discovery and translation Spatial omics technologies have transformed how we study tissue biology.However, translating these discoveries into robust, actionable biomarkers remains a major bottleneck, limited by a lack of
- CubaseBio — Cubase Bio is a biotechnology business that focuses on spatial biology tools. It creates solutions for 3D spatial analysis to speed up drug discovery.
- SampleFacts — Next generation Dried Blood Spot sampling – separating cells and plasma at the point of collection.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Seed, Series A
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 32
- Round size: Series A $1.3M–$73M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- BOOST Pharma — Boost Pharma: Developing a stem cell therapy for Osteogenesis Imperfecta.
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
- Umecrine Cognition — Umecrine Cognition is a Swedish clinical-stage pharmaceutical company developing a novel class of drugs to treat neurological disorders of the brain.
Sting – Stockholm Innovation & Growth enables talented people to turn their ideas into sustainable businesses. The support they offer includes qualified coaching in business development, a business angel network, a venture capital fund, a recruitment service, and an international network of investors, business contacts and experts. Itcontribute to the success of Sweden’s future technology companies by helping them to grow and compete internationally.
Show more...Investment focus
- Industry: Software, Apps, Medical
- Stage:Seed, Pre-Seed
- Geography: Sweden
Investor stats
- Total investments: 16
- Round size: Seed $216k–$724k; Pre-Seed $366k–$611k
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Prion — Prion makes it quick and easy for the preschool staff to give parents insight into what happens at preschool - together with the children. The app is available free for iPhone, Android and iPad.
- Texelio — Texelio a company who is set to redefine financial market news by developing AI which empowers the customers of Retail banks, Online Brokers and Investment Service platforms.
- Minnemera — Minnemera develops digital neurocognitive tests.
Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.
Show more...Investment focus
- Industry: Health Care, Mobile, Medical
- Stage:Seed, Pre-Seed, Angel
- Geography: Sweden, France, United Kingdom
Investor stats
- Total investments: 10
- Round size: Seed $400k–$5.3M; Pre-Seed $541k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Noala — Play interactive exercises and have weekly video calls with your own speech and language professional to overcome your communication
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Medoma — Medoma is a Swedish virtual ward company that offer patients acute hospital care in their home instead of in the hospital.
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more...Investment focus
- Industry: Health Care, Medical, Fitness
- Stage:Seed, Series A
- Geography: The Netherlands, Israel, Germany
Investor stats
- Total investments: 20
- Round size: Seed $423k–$6.3M; Series A $3M–$20M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Plasmacure — Plasmacure develops innovative plasma technology for wound care. Discover how cold plasma is transforming the treatment of chronic wounds.
- Mirantus Health — Mirantus is building a distributed healthcare provider to improve access to care for underserved patients. Through healthcare services (Mirantus Care) and cloud-solutions (Mirantus OS), Mirantus empowers doctors to efficiently treat patients who were difficult to reach before. This improves healthcare access for patients, allows physicians to earnmore, while saving payors billions in downstream costs. Mirantus is on a mission to get every specialist physician in Europe to participate in distributed healthcare, to improve healthcare access for 100M+ underserved patients.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Sweet Capital is the private investment fund of the founders of King.com (Candy Crush Saga), following their $5.9b sale to Activision Blizzard in 2015 (ATVI:US; acq. MSFT:US).
Show more...Investment focus
- Industry: Apps, Software, Mobile
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Sweden
Investor stats
- Total investments: 65
- Round size: Seed $1.9M–$5M; Series A $3M–$32M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Pachama — Harnessing AI to drive carbon capture and protect global forests
- Aula Education — Aula's created by educators to make every learning experience truly engaging. See how our simple, social platform can transform your digital learning environment.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more...Investment focus
- Industry: Pharmaceutical, Medical, Health Care
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden, United States
Investor stats
- Total investments: 9
- Round size: Seed $1M–$2.9M; Series A $2.3M–$73M; Venture - Series Unknown $794k–$1.5M
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Mimbly — Mimbly creates sustainable water solution with a focus on water usage and micro-plastics. Our product The mimbox, recycles up to 70% of the water from washing machines while capturing the micro plastics released.
- NSS Water — NSS Water specializes in innovative water purification technology for high-tech sectors such as semiconductors.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Tim Jackson is the Founder, CEO, General Partner & Partner of Walking Ventures & he attended University of Oxford in in 1983.
Show more...Investment focus
- Industry: Internet, Software, E-Commerce
- Stage:Seed, Angel, Pre-Seed
- Geography: United Kingdom, United States, Sweden
Investor stats
- Total investments: 18
- Round size: Seed $170k–$2.5M; Angel $273k–$707k
- Lead/follow: 11% lead, 89% follow
Portfolio highlights
- Cera — In five years, Cera has expanded to 10,000+ staff across the UK and Germany, delivering 40,000+ healthcare visits a day, and has grown from zero to nearly $300M revenues. Every day, Cera delivers healthcare services equivalent to several dozen hospitals or 1,000 care homes, and has grown 100-fold over the past two years making it one of the fastestgrowing businesses in Europe.Cera currently holds more than 300+ partnerships with the NHS and local authorities, and the company’s technology is used by 2,000+ businesses nationwide. It’s technology predicts health deteriorations in patients 30-fold faster than traditional care companies, with its Professional Carers and Nurses responding to over 5,000 ‘high risk’ alerts each day.Since the outset of the COVID-19 pandemic, Cera has delivered 10 million healthcare visits in people’s homes, created 10,000 jobs, and licensed it’s recruitment technology to the UK Government Department of Health to recruit 50,000+ people into healthcare careers. Cera was co-founded by entrepreneur, physician and policy expert Dr Ben Maruthappu, and its advisory board is chaired by Sir David Behan, the former CEO of the Care Quality Commission. Cera’s technology and care network have been recognised by over 30 industry awards including Deloitte Fast 50 (#8 in 2021, down from #26 in 2020), Sunday Times Fast Track and Most Outstanding Home Care Provider.
- CloudNC — CloudNC CAM Assist your CAM programming co-pilot. Automate your CAM programming. From setup to CAM program in seconds for 3-axis prismatic parts.
- Credit Kudos — Credit Kudos builds products using Open Banking so credit providers can approve more people and lower risk. Explore now!
GOBIA Enterprises is owned by Jan G Smith who has been active in the pharmaceutical industry.
Show more...Investment focus
- Industry: Medical, Health Care, Eyewear
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Sweden
Investor stats
- Total investments: 3
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Njord Medtech — Njord develops Medtech products to help improve productivity at hospitals.
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
20 North Street is the name HDR Partners uses when adding investors and industrial experience to small growth companies.
Show more...Investment focus
- Industry: Medical, mHealth, Wireless
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Coala Life — Coala Life is a Swedish medical technology and life science company that focuses on heart diagnostics and digital health. The company has developed a portfolio of solutions based on the Coala, a patented and commercial service for remote monitoring and self-screening of heart sounds and ECG. The Coala is available direct to consumers and theCoala Pro is offered to healthcare professionals to enable smart, digital cardiac assessments.
John Bloom John C. Bloom holds a B.S. degree in biology from the University of Pittsburgh and doctorates in veterinary medicine and experimental hematology from the University of Pennsylvania. He completed his postdoctoral training at the Jefferson Medical College in hematology/oncology and served on the Faculty of the University off Pennsylvania School of Veterinary Medicine as Chief, Clinical Laboratory Medicine, before joining Smith Kline & French Laboratories as Associate Director of Pathology. Dr. Bloom has been active in the fields of toxicology, clinical risk assessment and translational biomarker research within the pharmaceutical industry, FDA and Institute of Medicine and has authored several manuscripts, chapters, reviews and texts on these topics. He served as Head, Clinical Pathology, in the Toxicology Division of Lilly Research Laboratories, where he subsequently moved to the Medical Division to establish the departments of Experimental Medicine and Clinical Diagnostic Services, which were responsible for translational biomarker research; and laboratory, ECG, imaging and specimen banking support for global clinical development, respectively. Upon his retirement from Lilly in 2009 he established Bloom Consulting Services, LLC, which he serves as President, and was appointed Consultant, Office of the Center Director, FDA. Dr. Bloom holds adjunct academic appointments at the University of Pennsylvania and Purdue University.
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Doctrin — At Doctrin, they are passionate about improving healthcare. They strive to make patients healthier and happier, and healthcare professionals more effective at work. They achieve this by providing digital tools automating and simplifying as much of the patient journey as possible, for as many patients as possible.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 117
- Lead/follow: no public data
Portfolio highlights
- Noema Pharma — BEYOND SYMPTOM CONTROL Developing therapies to help both orphan and larger patient populations with conditions of the brain and nervous system live their li ...
- Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
- Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Zentynel Frontier is a investment firm.
Show more...Investment focus
- Industry: Health Care, Baby, Fitness
- Stage:Series A, Seed, Angel
- Geography: United States, Sweden
Investor stats
- Total investments: 9
- Lead/follow: no public data
Portfolio highlights
- Asclepii — Asclepii is an R&D startup focused on hyper-scaling regenerative medicine through Artemis, a product that aims to turn a $30.000 cell therapy into $300.
- MultiplAI Health — Universal genomic screening for virtually any complex diseases, including cardiovascular disorders and cancer.
- Xeptiva Therapeutics — Xeptiva Therapeutics is an innovative biotech that develops novel therapies for the veterinary market
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Series A, Series D, Series B
- Geography: Sweden, Germany, United States
Investor stats
- Total investments: 5
- Lead/follow: no public data
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
- Signifier Medical Technologies — Driving Innovation in the Sleep Market Signifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.
InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and whereNordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Series B, Series C
- Geography: Sweden, Denmark, United States
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Silecs — PiBond manufactures materials used in electronic devices, including patterning materials for semiconductors and optical materials. We also develop complete solutions that allow our clients to focus on creating innovative products.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
Jens Mogensen is an Angel Investor.
Show more...Investment focus
- Industry: Medical, Life Science, Biotechnology
- Stage:Series A
- Geography: Sweden
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
Christian W. Jansson
Show more...Investment focus
- Industry: Medical, Software, Health Care
- Stage:Seed
- Geography: Sweden
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Min Doktor — Min Doktor was founded by Swedish doctors in Lund with a clear vision, namely greater efficiency by simplifying the patient. We want to make health care available by allowing you to meet experienced doctors on your terms. When you have time, wherever you are and with technology you are used to using.
- PainDrainer — PainDrainer AB is a Swedish company founded 2018 by an experienced entrepreneur, a software architect, as well as an academic graduate well proficient in pain therapies. The aim of the company is to deliver solutions to unmet clinical needs for chronic, non-malignant, pain patients, using advanced Artificial Intelligent systems.
Medical Investor funding in Sweden at a glance
Stats across 264 deals from 281 investors.
Access all 281 investors in Sweden Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Investors in Sweden investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 281 investors investing in Sweden Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!